Cargando…
KRAS Binders Hidden in Nature
Natural products have proven to be a rich source of molecular architectures for drugs. Here, an integrated approach to natural product screening is proposed, which uncovered eight new natural product scaffolds for KRAS—the most frequently mutated oncogenic driver in human cancers, which has remained...
Autores principales: | Bergner, Andreas, Cockcroft, Xiaoling, Fischer, Gerhard, Gollner, Andreas, Hela, Wolfgang, Kousek, Roland, Mantoulidis, Andreas, Martin, Laetitia J., Mayer, Moriz, Müllauer, Barbara, Siszler, Gabriella, Wolkerstorfer, Bernhard, Kessler, Dirk, McConnell, Darryl B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772028/ https://www.ncbi.nlm.nih.gov/pubmed/31231840 http://dx.doi.org/10.1002/chem.201902810 |
Ejemplares similares
-
Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019) -
Reply to Tran et al.: Dimeric KRAS protein–protein interaction stabilizers
por: Kessler, Dirk, et al.
Publicado: (2020) -
Fragment Optimization
of Reversible Binding to the
Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS(G12C) Inhibitor
por: Bröker, Joachim, et al.
Publicado: (2022) -
Getting a Grip on the Undrugged: Targeting β‐Catenin with Fragment‐Based Methods
por: Kessler, Dirk, et al.
Publicado: (2021) -
PI by NMR: Probing CH–π Interactions in Protein–Ligand Complexes by NMR Spectroscopy
por: Platzer, Gerald, et al.
Publicado: (2020)